These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 30506225)
1. Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections. Zhou Y; Gao F; Chen C; Ma L; Yang T; Liu X; Liu Y; Wang X; Zhao X; Que C; Li S; Lv J; Cui Y; Yang L Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):361-370. PubMed ID: 30506225 [TBL] [Abstract][Full Text] [Related]
2. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis. Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections. Adane ED; Herald M; Koura F Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478 [TBL] [Abstract][Full Text] [Related]
4. [Population pharmacokinetics of vancomycin from severe in patients with lower respiratory tract infection]. Yang W; He B; Deng CH Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):205-209. PubMed ID: 28297816 [No Abstract] [Full Text] [Related]
5. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children. Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the age dependency of vancomycin clearance by population pharmacokinetic modeling. Usman M; Fobker M; Hempel G Int J Clin Pharmacol Ther; 2018 Feb; 56(2):56-63. PubMed ID: 29319495 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of vancomycin in Chinese infants . Sheng XY; Chen CY; Ma LY; Liu YO; Zhou Y; Cui YM Int J Clin Pharmacol Ther; 2017 Jul; 55(7):558-566. PubMed ID: 28406088 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients. Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock. Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy. Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475 [TBL] [Abstract][Full Text] [Related]
11. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population. Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677 [TBL] [Abstract][Full Text] [Related]
13. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients. Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units. Lin Z; Chen DY; Zhu YW; Jiang ZL; Cui K; Zhang S; Chen LH Sci Rep; 2021 Jan; 11(1):2670. PubMed ID: 33514803 [TBL] [Abstract][Full Text] [Related]
15. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration]. Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens. Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622 [TBL] [Abstract][Full Text] [Related]
17. Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients. Shen K; Yang M; Fan Y; Liang X; Chen Y; Wu J; Yu J; Zhang H; Wang R; Zhang F; Hang J; Wen X; Li H; Shen L; Zhang Z; Wu S; Shen B; Huang W; Chang C; Shen Y; Ren H; Yuan Q; Song X; Luo X; Zhang H; Yang W; Yang J; Zhang J Clin Infect Dis; 2018 Nov; 67(suppl_2):S256-S262. PubMed ID: 30423042 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease. Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of vancomycin in adult and geriatric patients: comparison of eleven approaches. Sánchez JL; Dominguez AR; Lane JR; Anderson PO; Capparelli EV; Cornejo-Bravo JM Int J Clin Pharmacol Ther; 2010 Aug; 48(8):525-33. PubMed ID: 20650044 [TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies. Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]